Literature DB >> 23329847

Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.

Min-Kyeong Kim1, Bu-Nam Jeon, Dong-In Koh, Kyung-Sup Kim, So-Yoon Park, Chae-Ok Yun, Man-Wook Hur.   

Abstract

The human POZ domain and Krüppel-like zinc finger (POK) family proteins play important roles in the regulation of apoptosis, cell proliferation, differentiation, development, oncogenesis, and tumor suppression. A novel POK family transcription factor, BTB/POZ and zinc finger domains factor on chromosome 1 (BOZF-1; also called ZBTB8A), contains a POZ domain and two C2H2-type Krüppel-like zinc fingers and is localized at nuclear speckles. Compared with paired normal tissues, BOZF1 expression is increased in cancer tissues of the prostate, breast, and cervix. BOZF1 repressed the transcription of p21WAF/CDKN1A by acting on the proximal promoter concentrated with Sp1-binding GC boxes. BOZF1 competed with Sp1 in binding to GC boxes 1-5/6 of the CDKN1A proximal promoter. In addition, BOZF1 interacted with p53 and decreased the acetylation of p53 by p300, which reduced the DNA binding activity of p53 at the far distal p53-binding element. BOZF1 blocked the two major molecular events that are important in both constitutive and inducible transcription activation of CDKN1A. BOZF1 is unique in that it bound to all the proximal GC boxes to repress transcription, and it inhibited p53 acetylation without affecting p53 stability. BOZF1 might be a novel proto-oncoprotein that stimulates cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329847      PMCID: PMC3591615          DOI: 10.1074/jbc.M112.416297

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.

Authors:  P P McKenzie; S M Guichard; D S Middlemas; R A Ashmun; M K Danks; L C Harris
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

Review 3.  Proliferation, cell cycle and apoptosis in cancer.

Authors:  G I Evan; K H Vousden
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

5.  POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.

Authors:  Dong-Kee Lee; Dongchul Suh; Howard J Edenberg; Man-Wook Hur
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

6.  The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding.

Authors:  K M Lee; W I Choi; D I Koh; Y J Kim; B N Jeon; J H Yoon; C E Lee; S H Kim; J Oh; M W Hur
Journal:  Oncogene       Date:  2011-08-01       Impact factor: 9.867

7.  Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line.

Authors:  A L Gartel; E Goufman; F Najmabadi; A L Tyner
Journal:  Oncogene       Date:  2000-10-26       Impact factor: 9.867

8.  Negative control of p53 by Sir2alpha promotes cell survival under stress.

Authors:  J Luo; A Y Nikolaev; S Imai; D Chen; F Su; A Shiloh; L Guarente; W Gu
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

9.  Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.

Authors:  G Koutsodontis; I Tentes; P Papakosta; A Moustakas; D Kardassis
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

10.  Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo.

Authors:  Jianyuan Luo; Muyang Li; Yi Tang; Monika Laszkowska; Robert G Roeder; Wei Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  5 in total

1.  Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene.

Authors:  Jae-Hyeon Yoon; Won-Il Choi; Bu-Nam Jeon; Dong-In Koh; Min-Kyeong Kim; Myung-Hwa Kim; Jungho Kim; Sujin Susanne Hur; Kyung-Sup Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2014-01-01       Impact factor: 5.157

2.  Comparatively analyzing the liver-specific transcriptomic profiles in Kunming mice afflicted with streptozotocin- and natural food-induced type 2 diabetes mellitus.

Authors:  Yanjun Wu; Xiangxing Zhu; Arome Solomon Odiba; Zisheng Lin; Jiancong Wen; Daoyuan Gong; Jing Liang; Shuguang Wu; Ganqiu Lan
Journal:  Mol Biol Rep       Date:  2021-11-30       Impact factor: 2.316

3.  Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer.

Authors:  Yonggang Tan; Hongzhuan Yin; Heying Zhang; Jun Fang; Wei Zheng; Dan Li; Yue Li; Wei Cao; Cheng Sun; Yusi Liang; Juan Zeng; Huawei Zou; Weineng Fu; Xianghong Yang
Journal:  Oncotarget       Date:  2015-07-10

4.  Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating transcription of p21/CDKN1A and RB upon exposure to genotoxic stress.

Authors:  Bu-Nam Jeon; Min-Kyeong Kim; Jae-Hyeon Yoon; Min-Young Kim; Haemin An; Hee-Jin Noh; Won-Il Choi; Dong-In Koh; Man-Wook Hur
Journal:  Nucleic Acids Res       Date:  2014-09-22       Impact factor: 16.971

5.  The Curcumin Analog CH-5 Exerts Anticancer Effects in Human Osteosarcoma Cells via Modulation of Transcription Factors p53/Sp1.

Authors:  Felipe Teixeira Lima; Viviane Seba; Gabriel Silva; Guilherme Silva Torrezan; Carlos Roberto Polaquini; Vitor Caressato Pinhanelli; Seung J Baek; Ana Lúcia Fachin; Luis Octavio Regasini; Mozart Marins
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.